Teresa Surace

Verified @gmail.com

Psychiatrist at ASST Monza – San Gerardo Hospital, via G.B. Pergolesi 33, 20900 Monza, Italy

Teresa Surace


         Download Compact PDF  
https://researchid.co/teresa.surace
28

Scopus Publications

Scopus Publications

  • Clinical and biochemical correlates of rapid cycling in bipolar disorder: A 20-year inpatient study
    Anna Pan, Enrico Capuzzi, Francesca Legnani, Luigi Piccirilli, Martina Di Paolo, Alessandro Ceresa, Cecilia Maria Esposito, Luisa Cirella, Teresa Surace, Ilaria Tagliabue, Massimo Clerici, Massimiliano Buoli
    European Journal of Psychiatry, 2026
  • Which clinical factors and biochemical parameters differentiate major depressive disorder with versus without lifetime psychotic symptoms?
    Cecilia Maria Esposito, Francesca Legnani, Jennifer L. Barkin, Alessandro Ceresa, Guido Nosari, Martina Di Paolo, Luisa Cirella, Teresa Surace, Ilaria Tagliabue, Enrico Capuzzi, Antonios Dakanalis, Massimo Clerici, Massimiliano Buoli
    International Journal of Psychiatry in Clinical Practice, 2026
    OBJECTIVE: Major depressive disorder (MDD) is a prevalent disabling condition, with psychotic features complicating its course and management. Purpose of the study is to identify clinical and biochemical factors differentiating psychotic from non-psychotic MDD. METHODS: -test for continuous variables and Chi-square tests for categorical ones. The statistically significant continuous variables were inserted in a binary logistic regression model as independent predictors of lifetime psychotic symptoms. RESULTS: = 0.004) than the counterpart. CONCLUSIONS: Lifetime psychotic symptoms confer a more severe course of illness in patients with MDD. No biochemical parameter resulted as a biomarker of MDD psychotic subtype.
  • Is Pilates effective in improving depressive disorders? A comprehensive overview
    Francesca Legnani, Lorenzo Tassi, Teresa Surace, Enrico Capuzzi, Alice Caldiroli, Massimo Clerici, Massimiliano Buoli
    International Clinical Psychopharmacology, 2025
    Depressive disorders are disabling conditions that account for high social costs. Pilates demonstrated to have several beneficial effects on health. Objective of this manuscript was to systematically review the literature about the effects of Pilates on depressive disorders. A bibliographic search was conducted in the main database sources (Pubmed, Medline, and Scopus). The inclusion criteria consisted of articles written in English language about the effectiveness of Pilates on depressive symptoms. Most of included studies are randomized controlled trials (10 out of 12). The available literature agrees in indicating that Pilates is effective in improving depressive symptoms especially when compared to inactivity and when this practice is administered for a medium-long period (8–16 weeks). In addition, Pilates seems to have at least comparable effectiveness than aerobic exercise. Pilates can be considered a reliable complementary treatment for people with depressive disorders. These findings should be interpreted considering the different types of practice administered as well as the different duration of the programs or rating scales used to assess mood symptoms. Studies with a more homogenous design are needed to confirm and make generalizable the results presented in this review.
  • Gender Differences in Clinical and Biochemical Variables of Patients Affected by Bipolar Disorder
    Luigi Piccirilli, Enrico Capuzzi, Francesca Legnani, Martina Di Paolo, Anna Pan, Alessandro Ceresa, Cecilia Maria Esposito, Luisa Cirella, Teresa Surace, Ilaria Tagliabue, Massimo Clerici, Massimiliano Buoli
    Brain Sciences, 2025
    Introduction: Bipolar disorder (BD) affects over 1% of the global population and significantly impacts psychosocial functioning and life expectancy. This manuscript has the objective of investigating gender differences in the clinical and biochemical parameters of patients affected by BD. Methods: This retrospective cross-sectional study examined 672 patients diagnosed with BD in psychiatric wards in Milan and Monza. Clinical data and biochemical parameters were collected on the first day of hospitalization. Independent sample t-tests, chi-square tests and binary logistic regressions were performed to identify gender differences in BD. Results: With regard to univariate analyses, women were found to be more susceptible to psychiatric comorbidities (χ2 = 12.75, p < 0.01), medical comorbidities (χ2 = 45.38, p < 0.01), obesity (χ2 = 6.75, p = 0.01) and hypercholesterolemia (χ2 = 23.54, p < 0.01), as well as to having more mood episodes in the year prior to hospitalization (t = 5.69, p < 0.01). Men were found to be more likely to develop psychotic symptoms (χ2 = 4.40, p = 0.04), to be tobacco smokers (χ2 = 15.13, p < 0.01) and to have substance abuse disorders (χ2 = 14.66, p = <0.01). Logistic regression analyses showed that women compared to men showed more psychiatric comorbidity (p < 0.01), higher Global Assessment of Functioning (GAF) scores (p = 0.05) and higher total cholesterol plasma levels (p < 0.01); however, they also had fewer red blood cells (p < 0.01) and lower creatinine plasma levels (p < 0.01). Conclusions: Female patients (compared to males) exhibited higher levels of global functioning despite the higher frequency of psychiatric comorbidity and susceptibility to metabolic complications; consistent with earlier studies, female patients also showed higher cholesterol levels. Further studies will have to confirm the present findings and identify gender-related clinical pathways for the management of BD.
  • Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia
    Paola Bucci, Armida Mucci, Giulia M. Giordano, Edoardo Caporusso, Luigi Giuliani, Dino Gibertoni, Alessandro Rossi, Paola Rocca, Alessandro Bertolino, Silvana Galderisi, Giuseppe Piegari, Eleonora Merlotti, Francesco Brando, Marco Papalino, Vitalba Calia, Raffaella Romano, Stefano Barlati, Giacomo Deste, Paolo Valsecchi, Federica Pinna, Alice Lai, Silvia Lostia Di Santa Sofia, Maria Salvina Signorelli, Laura Fusar Poli, Teresa Surace, Giovanni Martinotti, Chiara Montemitro, Silvia Fatricelli, Mario Altamura, Eleonora Angelini, Antonella Elia, Pietro Calcagno, Martino Belvederi Murri, Simone Cattedra, Francesca Pacitti, Rodolfo Rossi, Valentina Socci, Laura Giusti, Anna Salza, Silvia Mammarella, Andrea de Bartolomeis, Angela Favaro, Enrico Collantoni, Paolo Meneguzzo, Matteo Tonna, Paolo Ossola, Maria Lidia Gerra, Carla Gramaglia, Valeria Binda, Eleonora Gambaro, Claudia Carmassi, Barbara Carpita, Ivan Mirko Cremone, Giulio Corrivetti, Giammarco Cascino, Gianfranco Del Buono, Roberto Brugnoli, Anna Comparelli, Valentina Corigliano, Antonio Buzzanca, Nicoletta Gerardi, Marianna Frascarelli, Andrea Fagiolini, Arianna Goracci, Simone Bolognesi, Alberto Siracusano, Giorgio Di Lorenzo, Michele Ribolsi, Cristiana Montemagni, Cecilia Riccardi, Elisa Del Favero, and
    European Archives of Psychiatry and Clinical Neuroscience, 2024
    The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). The present study aimed at assessing, in a large sample of SCZ (n = 601), the agreement between patients and their informants on CAI ratings, to explore patients’ insight in their cognitive deficits and its relationships with clinical and functional indices. Agreement between patient- and informant-based ratings was assessed by the Gwet’s agreement coefficient. Predictors of insight in cognitive deficits were explored by stepwise multiple regression analyses. Patients reported lower severity of cognitive impairment vs. informants. A substantial to almost perfect agreement was observed between patients’ and informants’ ratings. Lower insight in cognitive deficits was associated to greater severity of neurocognitive impairment and positive symptoms, lower severity of depressive symptoms, and older age. Worse real-life functioning was associated to lower insight in cognitive deficit, worse neurocognitive performance, and worse functional capacity. Our findings indicate that the CAI is a valid co-primary measure with the interview to patients providing a reliable assessment of their cognitive deficits. In the absence of informants with good knowledge of the subject, the interview to the patient may represent a valid alternative.
  • Which clinical factors delay proper treatment in panic disorder? A cross-sectional multicentric study
    T. Surace, M. Buoli, L. M. Affaticati, G. Esposito, E. Capuzzi, L. Colzani, D. La Tegola, E. Biagi, F. Colmegna, A. Caldiroli, M. Clerici
    Early Intervention in Psychiatry, 2024
    AimThe aim of the present study was to identify clinical and socio‐demographic factors associated with duration of untreated illness (DUI) in patients affected by panic disorder (PD).MethodsData were collected from patients' medical records (N = 157) of two mental health services respectively located in Milan and in Monza (Italy). Correlation analyses and analysis of variance (ANOVAs) were run to analyse the relation between DUI and quantitative/qualitative variables respectively. Statistically significant variables in uni‐ variate analyses were then inserted in a linear multivariable regression model (backward procedure).ResultsMean DUI was 27.33 (±50.56) months. Patients with an earlier age at onset (r = −0.270; p < .01), a longer duration of illness (r = 0.483; p < .01) and who received a lifetime psychotherapy (F = 6.86; p = .01) had a longer DUI. The final global model showed that a longer DUI was associated with pre‐onset poly‐substance misuse (p = .05) and a longer duration of illness (p < .01).ConclusionThe results of our study showed that a longer DUI was predicted by clinical factors such as the presence of a pre‐onset poly‐substance use disorder and that delayed proper treatment can lead to a chronicization of PD, as indicated by a longer duration of illness. Further studies are needed to in‐depth investigate the role of DUI in influencing the course and outcome of anxiety disorders, including PD.
  • Sociodemographic and clinical factors associated with prescription of first- versus second-generation long-acting antipsychotics in incarcerated adult males
    Enrico Capuzzi, Carla Laura Di Forti, Alice Caldiroli, Francesca Cova, Teresa Surace, Massimiliano Buoli, Massimo Clerici
    International Clinical Psychopharmacology, 2024
    Information on patterns of prescription of long-acting injection (LAI) antipsychotics among people who are incarcerated is lacking. Therefore, we aimed to evaluate prescribing rates for first-generation antipsychotic (FGA)-LAI versus second-generation antipsychotic (SGA)-LAI and to identify the factors associated with the prescription of one of the two classes of LAI. A cross-sectional study was conducted among incarcerated adult males hosted in Monza detention center between January 2013 and April 2023. Socio-demographic and clinical data were retrospectively collected. Descriptive and univariate statistics as well as logistic regression analyses were performed. Data were available for 135 consecutive incarcerated adult males with different mental disorders who received a LAI as part of their treatment. 75.6% of our sample was treated with FGA-LAIs, with haloperidol as the most commonly prescribed drug, followed by zuclopentixol and aripiprazole. Diagnosis of bipolar disorder and concomitant administration of antidepressants were statistically significant predictors of SGA-LAI prescription. Some patients’ characteristics may influence prescription patterns in prison. Further longitudinal studies with larger samples should confirm these findings.
  • Which sociodemographic and clinical characteristics are associated with recurrent incarcerations in adult male people who are incarcerated? A cross-sectional study
    Enrico Capuzzi, Alice Caldiroli, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Arianna Manzoni, Francesca Cova, Carmen Di Brita, Teresa Surace, Stefania Bilardo, Paola Rubelli, Emanuele Truisi, Matteo Di Valentin, Massimiliano Buoli, Massimo Clerici
    Journal of Forensic Psychiatry and Psychology, 2024
    Although risk factors for recidivism were extensively studied, re-incarcerations still account for a disproportionate amount of overall service use and cost. Therefore, the main objectives of the study were (1) to estimate the prevalence of re-incarcerations in a sample of male incarcerated people and (2) to verify if some socio-demographic and clinical features including impulsivity can be risk factors of re-incarceration. We conducted a cross-sectional study recruiting 479 newly arrived incarcerated people in an Italian detention centre, between 2018 and 2022. The incarcerated individuals were interviewed to collect clinical information. Impulsivity was assessed by the Barratt Impulsiveness Scale (BIS-11). A total of 479 consecutive male incarcerated people was included. Two hundred and seventy-six of them (57.6%) had previously been incarcerated. Logistic regression analysis showed that having higher age, to be married or in relationship, to have low-medium level of education, housing instability, low or no income, cocaine use disorder in the last year and a history of non-suicidal self-injuries increased the likelihood of recurrent incarcerations. Moreover, re-incarceration was associated with higher rate of personality disorders and higher scores on attentional and motor impulsivity. Reintegration programs should address some risk factors associated with re-incarceration and promote social rehabilitation among incarcerated individuals.
  • Are There Any Differences in Clinical and Biochemical Variables between Bipolar Patients with or without Lifetime Psychotic Symptoms?
    Cecilia Maria Esposito, Jennifer L. Barkin, Alessandro Ceresa, Guido Nosari, Martina Di Paolo, Francesca Legnani, Luisa Cirella, Teresa Surace, Ilaria Tagliabue, Enrico Capuzzi, Alice Caldiroli, Antonios Dakanalis, Pierluigi Politi, Massimo Clerici, Massimiliano Buoli
    Journal of Clinical Medicine, 2023
    Introduction: Psychotic symptoms occur in more than half of patients affected by Bipolar Disorder (BD) and are associated with an unfavorable course of the disorder. The objective of this study is to identify the differences in the clinical and biochemical parameters between bipolar patients with or without psychotic symptoms. Methods: A total of 665 inpatients were recruited. Demographic, clinical, and biochemical data related to the first day of hospitalization were obtained via a screening of the clinical charts and intranet hospital applications. The two groups identified via the lifetime presence of psychotic symptoms were compared using t tests for quantitative variables and χ2 tests for qualitative ones; binary logistic regression models were subsequently performed. Results: Patients with psychotic BD (compared to non-psychotic ones) showed a longer duration of hospitalization (p < 0.001), higher Young Mania Rating Scale scores (p < 0.001), lower Global Assessment of Functioning scores (p = 0.002), a less frequent history of lifetime suicide attempts (p = 0.019), less achievement of remission during the current hospitalization (p = 0.028), and a higher Neutrophile to Lymphocyte Ratio (NLR) (p = 0.006), but lower total cholesterol (p = 0.018) and triglycerides (p = 0.013). Conclusions: Patients with psychotic BD have a different clinical and biochemical profile compared to their counterparts, characterized by more clinical severity, fewer metabolic alterations, and a higher grade of inflammation. Further multi-center studies have to confirm the results of this present study.
  • Air Pollution and Perinatal Mental Health: A Comprehensive Overview
    Teresa Surace, Cecilia Quitadamo, Alice Caldiroli, Enrico Capuzzi, Fabrizia Colmegna, Guido Nosari, Elisa Borroni, Luca Fedrizzi, Valentina Bollati, Angela Cecilia Pesatori, Michele Carugno, Massimo Clerici, Massimiliano Buoli
    Journal of Clinical Medicine, 2023
    Background: The aim of the present study was to summarise the available data about the link between air pollution exposure and the new-onset and severity of psychiatric disorders in pregnant women during the perinatal period. Materials and methods: We selected articles published until June 2022 on PubMed and the Web of Science. Pollutants included were PM2.5 (particulate matter 2.5 micrometres and smaller), PM10 (particulate matter 10 micrometres and smaller), NO2 (nitrogen dioxide), O3 (ozone), SO2 (sulphur dioxide), CO (carbon monoxide), PBDEs (polybrominated diphenyl ethers), PFAS (per- and polyfluoroalkyl substances), lead, and cadmium. The perinatal period was considered as the time of pregnancy until one year after childbirth. Results: Nine studies were included; most of them evaluated the association between exposure to air pollutants and the onset of Postpartum Depression (PPD). Two studies showed an association between, respectively, only PM2.5 and both PM2.5 and NO2 exposure and PPD onset 12 months after childbirth, while another study found a significant association between NO2 exposure and PPD occurrence 6 months after childbirth. PBDE blood levels were associated with more severe depressive symptoms. Lastly, one study observed a link between stressful symptoms and exposure to PM2.5, PM10 during pregnancy. Conclusion: More comprehensive and uniform studies are required to make a roadmap for future interventions, given the growing relevance of issues such pollution and mental health, particularly during the perinatal period.
  • Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome
    Alice Caldiroli, Lia Colzani, Enrico Capuzzi, Cecilia Quitadamo, Davide La Tegola, Teresa Surace, Stefania Russo, Mauro Capetti, Silvia Leo, Agnese Tringali, Matteo Marcatili, Francesco Zanelli Quarantini, Fabrizia Colmegna, Antonios Dakanalis, Massimiliano Buoli, Massimo Clerici
    Journal of Personalized Medicine, 2023
  • Novel pharmacotherapy targeting the positive symptoms of schizophrenia
    Enrico Capuzzi, Alice Caldiroli, Cecilia Quitadamo, Francesco Butturini, Teresa Surace, Massimo Clerici, Massimiliano Buoli
    Expert Opinion on Pharmacotherapy, 2023
  • Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review
    Alice Caldiroli, Enrico Capuzzi, Letizia M. Affaticati, Teresa Surace, Carla L. Di Forti, Antonios Dakanalis, Massimo Clerici, Massimiliano Buoli
    International Journal of Molecular Sciences, 2023
  • Which clinical factors and biochemical parameters are associated with late-life major depression?
    Massimiliano Buoli, Francesca Legnani, Guido Nosari, Anna Pan, Valentina Ciappolino, Cecilia Maria Esposito, Alessandro Ceresa, Martina Di Paolo, Teresa Surace, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Luisa Cirella, Francesco Zanelli Quarantini, Antonios Dakanalis, Massimo Clerici, Enrico Capuzzi, Alice Caldiroli
    International Journal of Psychiatry in Clinical Practice, 2023
  • Which Clinical and Biochemical Parameters Are Associated with Lifetime Suicide Attempts in Bipolar Disorder?
    Teresa Surace, Enrico Capuzzi, Alice Caldiroli, Alessandro Ceresa, Cecilia Maria Esposito, Anna Maria Auxilia, Ilaria Tagliabue, Martina Capellazzi, Francesca Legnani, Martina Di Paolo, Luisa Cirella, Francesco Zanelli Quarantini, Maria Salvina Signorelli, Eugenio Aguglia, Massimo Clerici, Massimiliano Buoli
    Diagnostics, 2022
  • Psychological well-being and family distress of Italian caregivers during the COVID-19 outbreak
    Laura Fusar‐Poli, Teresa Surace, Valeria Meo, Federica Patania, Chiara Avanzato, Alfredo Pulvirenti, Eugenio Aguglia, Maria Salvina Signorelli
    Journal of Community Psychology, 2022
  • Gender differences in clinical and biochemical parameters of patients consecutively hospitalized for unipolar depression
    Alessandro Ceresa, Cecilia Maria Esposito, Teresa Surace, Francesca Legnani, Luisa Cirella, Denise Cetti, Martina Di Paolo, Guido Nosari, Francesco Zanelli Quarantini, Marta Serati, Valentina Ciappolino, Alice Caldiroli, Enrico Capuzzi, Massimiliano Buoli
    Psychiatry Research, 2022
  • Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
    Massimiliano Buoli, Enrico Capuzzi, Alice Caldiroli, Alessandro Ceresa, Cecilia Maria Esposito, Cristina Posio, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Teresa Surace, Francesca Legnani, Luisa Cirella, Martina Di Paolo, Guido Nosari, Francesco Zanelli Quarantini, Massimo Clerici, Fabrizia Colmegna, Antonios Dakanalis
    Behavioral Sciences, 2022
  • The Psychological Impact of the COVID-19 Lockdown: A Comparison between Caregivers of Autistic and Non-Autistic Individuals in Italy
    Laura Fusar-Poli, Miriam Martinez, Teresa Surace, Valeria Meo, Federica Patania, Chiara Avanzato, Maria Salvina Signorelli, Eugenio Aguglia
    Brain Sciences, 2022
  • Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia
    Massimo Gennarelli, Palmiero Monteleone, Alessandra Minelli, Alessio Maria Monteleone, Alessandro Rossi, Paola Rocca, Alessandro Bertolino, Eugenio Aguglia, Mario Amore, Silvio Bellino, Antonello Bellomo, Massimo Biondi, Paola Bucci, Bernardo Carpiniello, Giammarco Cascino, Alessandro Cuomo, Liliana Dell’Osso, Massimo di Giannantonio, Giulia Maria Giordano, Carlo Marchesi, Lucio Oldani, Maurizio Pompili, Rita Roncone, Rodolfo Rossi, Alberto Siracusano, Elena Tenconi, Antonio Vita, Patrizia Zeppegno, Silvana Galderisi, Mario Maj, and
    World Journal of Biological Psychiatry, 2022
  • Accuracy of self-assessment of real-life functioning in schizophrenia
    Paola Rocca, , Claudio Brasso, Cristiana Montemagni, Silvio Bellino, Alessandro Rossi, Alessandro Bertolino, Dino Gibertoni, Eugenio Aguglia, Mario Amore, Ileana Andriola, Antonello Bellomo, Paola Bucci, Antonino Buzzanca, Bernardo Carpiniello, Alessandro Cuomo, Liliana Dell’Osso, Angela Favaro, Giulia Maria Giordano, Carlo Marchesi, Palmiero Monteleone, Lucio Oldani, Maurizio Pompili, Rita Roncone, Rodolfo Rossi, Alberto Siracusano, Antonio Vita, Patrizia Zeppegno, Silvana Galderisi, Mario Maj
    Npj Schizophrenia, 2021
  • Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
    Silvia Mariel Ferrucci, Simona Tavecchio, Luisa Angileri, Teresa Surace, Emilio Berti, Massimiliano Buoli
    Acta Dermato Venereologica, 2021
  • Lifetime prevalence of suicidal ideation and suicidal behaviors in gender non-conforming youths: a meta-analysis
    Teresa Surace, Laura Fusar-Poli, Lucia Vozza, Vito Cavone, Chiara Arcidiacono, Rossella Mammano, Lucia Basile, Alessandro Rodolico, Pablo Bisicchia, Pasquale Caponnetto, Maria Salvina Signorelli, Eugenio Aguglia
    European Child and Adolescent Psychiatry, 2021
  • Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life"
    Palmiero Monteleone, Giammarco Cascino, Alessio Maria Monteleone, Paola Rocca, Alessandro Rossi, Alessandro Bertolino, Eugenio Aguglia, Mario Amore, Enrico Collantoni, Giulio Corrivetti, Alessandro Cuomo, Antonello Bellomo, Enrico D’Ambrosio, Liliana Dell’Osso, Marianna Frascarelli, Giulia Maria Giordano, Luigi Giuliani, Carlo Marchesi, Cristiana Montemagni, Lucio Oldani, Federica Pinna, Maurizio Pompili, Rita Roncone, Rodolfo Rossi, Alberto Siracusano, Antonio Vita, Patrizia Zeppegno, Silvana Galderisi, Mario Maj
    Progress in Neuro Psychopharmacology and Biological Psychiatry, 2021
  • A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study
    Andrea Aguglia, Alessandro Cuomo, Andrea Amerio, Simone Bolognesi, Gabriele Di Salvo, Laura Fusar-Poli, Arianna Goracci, Teresa Surace, Gianluca Serafini, Eugenio Aguglia, Mario Amore, Andrea Fagiolini, Giuseppe Maina
    International Journal of Psychiatry in Clinical Practice, 2021
  • Psychometric properties of the Autism Spectrum Disorder in Adults Screening Questionnaire (ASDASQ) in a sample of Italian psychiatric outpatients
    Laura Fusar-Poli, Emanuele Bisso, Ilaria Concas, Teresa Surace, Silvia Tinacci, Antonio Vanella, Rosaria Furnari, Maria Salvina Signorelli, Lena Nylander, Eugenio Aguglia
    Research in Autism Spectrum Disorders, 2020
  • Mood disorders and outcomes in lung cancer patients undergoing surgery: A brief summery
    Maria Salvina Signorelli, Teresa Surace, Marcello Migliore, Eugenio Aguglia
    Future Oncology, 2020
  • The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials
    Laura Fusar-Poli, Teresa Surace, Antonio Vanella, Valeria Meo, Federica Patania, Rosaria Furnari, Maria Salvina Signorelli, Eugenio Aguglia
    Journal of Affective Disorders, 2019